Thoracoscopic segmentectomy for small-sized peripheral lung cancer. 2018

Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
Department of Thoracic Surgical Oncology, The Cancer Institute Hospital, Koto-ku, Tokyo, Japan.

BACKGROUND Lung segmentectomy is a therapeutic option in containing pathological diagnosis and radical cure for small-sized peripheral lung cancer. We retrospectively investigated the results of thoracoscopic segmentectomy (TS-S). METHODS From April 2008 to December 2016, 191 patients who underwent TS-S for small-sized peripheral lung cancer were reviewed retrospectively. Intentional indication of TS-S is peripheral radiologically noninvasive lung cancer whose tumor size is less than 2 cm in size with consolidation to tumor (C/T) ratio less than 0.5. Compromised indication is radiologically invasive lung cancer (C/T ration more than 0.5) which we can keep sufficient surgical margin. RESULTS We performed TS-S in 191 patients (81 males and 110 females, median age 66 years). The mean diameter of the nodules was 15 mm (range, 6-46 mm), and clinical IA/IB was 184/7, respectively. Intentional indication was 145 (76%) and compromised one was 46 (24%). The mean operation time was 169 min (range, 73-319 min) and the mean blood loss was 42 g (range, 0-2,900 g). One procedure was converted to open thoracotomy due to bleeding of pulmonary artery (conversion rate, 0.5%). The median chest drainage duration was 1 day (range, 1-9 days), and the median postoperative hospital stay was 7 days (range, 3-30 days). Postoperative complications occurred in 19 patients (10%), including air leak lasting more than 7 days in 3 patients, and late phase air leak in 1 patient. There was no 30-day mortality. Median follow-up was 52 months. The 5-year overall survival (OS) rates and relapse free survival rates, including deaths from all causes, were 93.4% and 90.8%, respectively. During this period, there were 4 distal recurrences after TS-S. However, there was no local recurrence. CONCLUSIONS Our result of TS-S was an acceptable. Appropriate selection of patient and surgical procedure in TS-S is important issue.

UI MeSH Term Description Entries

Related Publications

Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
January 2016, Journal of visualized surgery,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
August 2012, The Annals of thoracic surgery,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
June 2005, Nihon Geka Gakkai zasshi,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
August 2016, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
January 2022, Annals of surgical oncology,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
April 2022, The Thoracic and cardiovascular surgeon,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
January 2012, Kyobu geka. The Japanese journal of thoracic surgery,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
January 2023, Kyobu geka. The Japanese journal of thoracic surgery,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
December 2022, Thoracic cancer,
Mingyon Mun, and Masayuki Nakao, and Yosuke Matsuura, and Junji Ichinose, and Ken Nakagawa, and Sakae Okumura
January 2018, Seminars in thoracic and cardiovascular surgery,
Copied contents to your clipboard!